Please use this identifier to cite or link to this item:
|Title:||Vascular underpinning of COVID-19||Authors:||Wazny, Vanessa
Wu, Kan Xing
|Keywords:||Science::Medicine||Issue Date:||2020||Source:||Wazny, V., Siau, A., Wu, K. X. & Cheung, C. (2020). Vascular underpinning of COVID-19. Open Biology, 10(8). https://dx.doi.org/10.1098/rsob.200208||Journal:||Open Biology||Abstract:||COVID-19 management guidelines have largely attributed critically ill patients who develop acute respiratory distress syndrome, to a systemic overproduction of pro-inflammatory cytokines. Cardiovascular dysfunction may also represent a primary phenomenon, with increasing data suggesting that severe COVID-19 reflects a confluence of vascular dysfunction, thrombosis and dysregulated inflammation. Here, we first consolidate the information on localized microvascular inflammation and disordered cytokine release, triggering vessel permeability and prothrombotic conditions that play a central role in perpetuating the pathogenic COVID-19 cascade. Secondly, we seek to clarify the gateways which SARS-CoV-2, the causative COVID-19 virus, uses to enter host vascular cells. Post-mortem examinations of patients' tissues have confirmed direct viral endothelial infection within several organs. While there have been advances in single-cell RNA sequencing, endothelial cells across various vascular beds express low or undetectable levels of those touted SARS-CoV-2 entry factors. Emerging studies postulate alternative pathways and the apicobasal distribution of host cell surface factors could influence endothelial SARS-CoV-2 entry and replication. Finally, we provide experimental considerations such as endothelial polarity, cellular heterogeneity in organoids and shear stress dynamics in designing cellular models to facilitate research on viral-induced endothelial dysfunctions. Understanding the vascular underpinning of COVID-19 pathogenesis is crucial to managing outcomes and mortality.||URI:||https://hdl.handle.net/10356/148621||ISSN:||2046-2441||DOI:||10.1098/rsob.200208||Rights:||© 2020 The Author(s). Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Updated on Jan 21, 2022
Updated on Jan 21, 2022
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.